Section I
861 – 870 of 4726
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care
(
- Contribution to journal › Scientific review
-
Mark
Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status
(
- Contribution to journal › Article
-
Mark
Cosmetic outcome and symmetry for patients who have undergone bilateral therapeutic mammoplasty for breast cancer
(
- Contribution to journal › Article
-
Mark
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation : Implications for risk stratification of bladder cancer
(
- Contribution to journal › Article
-
Mark
Re : A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol. In press. http://doi.org/10.1016/j.eururo.2020.06.048
(
- Contribution to journal › Letter
-
Mark
Treatment-related leukopenia in anal cancer patients associated with worse outcome : results of a retrospective cohort study
(
- Contribution to journal › Letter
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
(
- Contribution to journal › Article
-
Mark
Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships
2020)(
- Other contribution › Miscellaneous
-
Mark
Statistic estimation of cell compressibility based on acoustophoretic separation data
(
- Contribution to journal › Article
-
Mark
LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target
(
- Contribution to journal › Article